These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3727818)

  • 21. [The elderly patient with urge incontinence or urge-stress incontinence - efficacy and cardiac safety of propiverine].
    Dorschner W; Stolzenburg JU; Griebenow R; Halaska M; Brünjes R; Frank M; Wieners F
    Aktuelle Urol; 2003 Mar; 34(2):102-8. PubMed ID: 14566693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapy of enuresis with a pediatric tablet of propiverin (Mictonettes)].
    Nentwich HJ
    Kinderarztl Prax; 1986 Jun; 54(6):329-33. PubMed ID: 3528628
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of symptomatic urinary incontinence in women].
    Voigt R; Halacka M; Al-Hasan A; Voigt P; Michels W
    Cesk Gynekol; 1989 Jun; 54(5):351-2. PubMed ID: 2791002
    [No Abstract]   [Full Text] [Related]  

  • 24. [Tolerance and effectiveness of propiverine hydrochloride in 752 patients with symptoms of detrusor hyperactivity and increased sensitivity and irritability of the urinary bladder: results of a study monitoring drug utilization].
    Halaska M; Martan A; Voigt R; Kaplan F; Raus K; Masata J; Klemenc J
    Ceska Gynekol; 1997 Oct; 62(5):259-64. PubMed ID: 9600163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of children with an unstable bladder using the new anticholinergic drug Mictonorm (author's transl)].
    Heller K
    Padiatr Padol; 1982; 17(1):115-20. PubMed ID: 7058055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical and urodynamic effects of oral propiverine therapy in neurogenic urinary incontinence. A multicenter study for optimizing dosage].
    Mazur D; Göcking K; Wehnert J; Schubert G; Herfurth G; Alken RG
    Urologe A; 1994 Sep; 33(5):447-52. PubMed ID: 7974935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug therapy of urinary incontinence].
    Schütz W
    Med Klin; 1980 Feb; 75(3):127-31. PubMed ID: 6103504
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of motor urge incontinence with the beta 2-sympathomimetic drug clenbuterol (author's transl)].
    Grüneberger A; Geier G
    Urologe A; 1981 May; 20(3):153-4. PubMed ID: 6115496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy and safety of propiverine on improvement of symptoms and QOL for female patients with wet overactive bladder].
    Kato M; Matsukawa Y; Kato K; Kondo A; Yamada S; Hattori R; Gotoh M
    Hinyokika Kiyo; 2008 Mar; 54(3):165-71. PubMed ID: 18411770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison between urodynamic findings obtained prior to and during treatment of women for urinary urge incontinence (author's transl)].
    Voigt R; Voigt P
    Zentralbl Gynakol; 1981; 103(22):1357-63. PubMed ID: 7340299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the bladder a reliable witness for predicting detrusor overactivity?
    Hashim H; Abrams P
    J Urol; 2006 Jan; 175(1):191-4; discussion 194-5. PubMed ID: 16406907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of vaginal estrogen therapy on urinary incontinence in postmenopause].
    Schär G; Köchli OR; Fritz M; Haller U
    Zentralbl Gynakol; 1995; 117(2):77-80. PubMed ID: 7709677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacological treatment of urinary incontinence and difficulty in emptying the bladder in women].
    Thind P; Lose G
    Ugeskr Laeger; 1985 Dec; 147(49):3989-92. PubMed ID: 2868553
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of urgency urinary incontinence in women using clenbuterol].
    Voigt R; Martan A; Halaska M; Sindlár M; Voigt P
    Cesk Gynekol; 1986 Mar; 51(2):76-80. PubMed ID: 3955692
    [No Abstract]   [Full Text] [Related]  

  • 35. Short- and long-term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence.
    Staskin DR; Te AE
    BJU Int; 2006 Jun; 97(6):1256-61. PubMed ID: 16686722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intravesical drug therapy in women with severe urge incontinence. Clinical experiences from a department of gynecology].
    Johansen JK; Lose G
    Ugeskr Laeger; 1999 Nov; 161(44):6052-5. PubMed ID: 10778341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
    Schmid DM; Sauermann P; Werner M; Schuessler B; Blick N; Muentener M; Strebel RT; Perucchini D; Scheiner D; Schaer G; John H; Reitz A; Hauri D; Schurch B
    J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combined treatment of voiding disorders in women with m-cholinolytic and alpha 1-adrenoblocker].
    Danilov VV; Vol'nykh IIu; Abdullaeva CK; Danilova TI
    Urologiia; 2004; (3):49-52. PubMed ID: 15199816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased prevalence of interstitial cystitis in women with detrusor overactivity refractory to anticholinergic therapy.
    Minaglia S; Ozel B; Bizhang R; Mishell DR
    Urology; 2005 Oct; 66(4):702-6. PubMed ID: 16230120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Urodynamic studies of female urinary incontinence. Personal experience].
    Carone R; Frea B; Tizzani A; Arena G; Ferrando U
    Minerva Urol; 1981; 33(1):41-2. PubMed ID: 7242508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.